Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...

Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...

We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous value they offer.

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...

(Reuters) - Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk (NYSE:NVO)'s Wegovy and Eli Lilly (NYSE:LLY)'s Zepbound result in both fat and ...

Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Sales of weight loss drug Wegovy more than doubled in the final ... or by people sending in photos of themselves.

In stark contrast, Wegovy only showed a weight loss of around 6% after 12 weeks and around 15% after 68 weeks in clinical studies. Amycretin outperformed Wegovy due to the differences in the ...